Patent ID: 8541412
Filing Date: 2013-09-24
Classification: A61P,C07D

Abstract:
1. A method of treating a condition selected from cancers of the colon, breast, liver, kidneys, brain, esophagus, melanomas, melanomas, cancers of the ovary, small cell lung cancers, cancers of the prostate and pancreas, and sarcomas in a subject in need thereof comprising administration of an effective amount of a compound selected from those of formula (I): wherein: m represents 1 or 2, n represents 1 or 2, A represents a pyrrolyl group which is unsubstituted or substituted by 1 to 3 linear or branched (C X represents a C(O), S(O) or SO R R R R it being understood that: a “heterocyclic group” means a mono- or bi-cyclic group which may contain from 5 to 8 members, which may contain from one to three hetero atoms selected from nitrogen, oxygen and sulphur, and which may contain one or more unsaturated bonds, wherein the heterocyclic group is optionally substituted by one or more groups selected from linear or branched (C “aryl” means a phenyl group which is optionally substituted by one or more groups selected from halogen atoms and linear or branched (C the notation its optical and geometric isomers, and addition salts thereof with a pharmaceutically acceptable acid or base.